109 related articles for article (PubMed ID: 24501773)
1. The known interactome of PTPIP51 in HaCaT cells—inhibition of kinases and receptors.
Brobeil A; Koch P; Eiber M; Tag C; Wimmer M
Int J Biochem Cell Biol; 2014 Jan; 46():19-31. PubMed ID: 24501773
[TBL] [Abstract][Full Text] [Related]
2. PTPIP51 in protein interactions: regulation and in situ interacting partners.
Brobeil A; Bobrich M; Tag C; Wimmer M
Cell Biochem Biophys; 2012 Jul; 63(3):211-22. PubMed ID: 22544307
[TBL] [Abstract][Full Text] [Related]
3. Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.
Dietel E; Brobeil A; Delventhal L; Tag C; Gattenlöhner S; Wimmer M
PLoS One; 2019; 14(5):e0216642. PubMed ID: 31075141
[TBL] [Abstract][Full Text] [Related]
4. Altered Protein Interactions of the Endogenous Interactome of PTPIP51 towards MAPK Signaling.
Brobeil A; Chehab R; Dietel E; Gattenlöhner S; Wimmer M
Biomolecules; 2017 Jul; 7(3):. PubMed ID: 28754031
[TBL] [Abstract][Full Text] [Related]
5. PTPIP51 is phosphorylated by Lyn and c-Src kinases lacking dephosphorylation by PTP1B in acute myeloid leukemia.
Brobeil A; Bobrich M; Graf M; Kruchten A; Blau W; Rummel M; Oeschger S; Steger K; Wimmer M
Leuk Res; 2011 Oct; 35(10):1367-75. PubMed ID: 21513978
[TBL] [Abstract][Full Text] [Related]
6. PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3β and PTP1B in situ.
Petri MK; Koch P; Stenzinger A; Kuchelmeister K; Nestler U; Paradowska A; Steger K; Brobeil A; Viard M; Wimmer M
Histol Histopathol; 2011 Dec; 26(12):1531-43. PubMed ID: 21972092
[TBL] [Abstract][Full Text] [Related]
7. PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor.
Petri MK; Brobeil A; Planz J; Bräuninger A; Gattenlöhner S; Nestler U; Stenzinger A; Paradowska A; Wimmer M
J Neurooncol; 2015 May; 123(1):15-25. PubMed ID: 25862004
[TBL] [Abstract][Full Text] [Related]
8. The Importance of the Right Framework: Mitogen-Activated Protein Kinase Pathway and the Scaffolding Protein PTPIP51.
Dietel E; Brobeil A; Gattenlöhner S; Wimmer M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30360441
[TBL] [Abstract][Full Text] [Related]
9. PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway.
Yu C; Han W; Shi T; Lv B; He Q; Zhang Y; Li T; Zhang Y; Song Q; Wang L; Ma D
Cell Signal; 2008 Dec; 20(12):2208-20. PubMed ID: 18771726
[TBL] [Abstract][Full Text] [Related]
10. PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway.
Brobeil A; Kämmerer F; Tag C; Steger K; Gattenlöhner S; Wimmer M
Biomolecules; 2015 Apr; 5(2):485-504. PubMed ID: 25893721
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-, transforming growth factor-beta-, retinoic acid- and 1,25-dihydroxyvitamin D3-regulated expression of the novel protein PTPIP51 in keratinocytes.
Stenzinger A; Schreiner D; Pfeiffer T; Tag C; Hofer HW; Wimmer M
Cells Tissues Organs; 2006; 184(2):76-87. PubMed ID: 17361080
[TBL] [Abstract][Full Text] [Related]
12. PTPIP51 inhibits non-small-cell lung cancer by promoting PTEN-mediated EGFR degradation.
He M; Wang X; Chen W; Zhang J; Xiong Y; Cao L; Zhang L; Zhao N; Yang Y; Wang L
Life Sci; 2022 May; 297():120293. PubMed ID: 35240162
[TBL] [Abstract][Full Text] [Related]
13. Orchestrating cellular signaling pathways-the cellular "conductor" protein tyrosine phosphatase interacting protein 51 (PTPIP51).
Brobeil A; Dietel E; Gattenlöhner S; Wimmer M
Cell Tissue Res; 2017 Jun; 368(3):411-423. PubMed ID: 27734150
[TBL] [Abstract][Full Text] [Related]
14. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.
Graness A; Hanke S; Boehmer FD; Presek P; Liebmann C
Biochem J; 2000 Apr; 347(Pt 2):441-7. PubMed ID: 10749673
[TBL] [Abstract][Full Text] [Related]
15. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
16. Memory and PTPIP51--a new protein in hippocampus and cerebellum.
Brobeil A; Viard M; Petri MK; Steger K; Tag C; Wimmer M
Mol Cell Neurosci; 2015 Jan; 64():61-73. PubMed ID: 25496818
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor-, epidermal growth factor-, or A-Raf-induced growth of HaCaT keratinocytes requires extracellular signal-regulated kinase.
Rössler OG; Thiel G
Am J Physiol Cell Physiol; 2004 May; 286(5):C1118-29. PubMed ID: 15075211
[TBL] [Abstract][Full Text] [Related]
18. Activation of cytosolic phospholipase A2alpha by epidermal growth factor (EGF) and phorbol ester in HeLa cells: different effects of inhibitors for EGF receptor, protein kinase C, Src, and C-Raf.
Matsuzawa Y; Kiuchi Y; Toyomura K; Matsumoto I; Nakamura H; Fujino H; Murayama T; Kawashima T
J Pharmacol Sci; 2009 Oct; 111(2):182-92. PubMed ID: 19783865
[TBL] [Abstract][Full Text] [Related]
19. PTPIP51 interaction with PTP1B and 14-3-3β in adipose tissue of insulin-resistant mice.
Bobrich M; Brobeil A; Mooren FC; Krüger K; Steger K; Tag C; Wimmer M
Int J Obes (Lond); 2011 Nov; 35(11):1385-94. PubMed ID: 21266951
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells.
Dietel E; Brobeil A; Tag C; Gattenloehner S; Wimmer M
Oncogenesis; 2018 Aug; 7(8):64. PubMed ID: 30139932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
